Target intelligence / Profile preview

Tubulin beta pseudogene 2 (TUBBP2)

Target: TUBBP2
Molecular classification: Other (Pseudogene)

Overview

Tubulin beta pseudogene 2 (TUBBP2) is classified as a pseudogene—a segment of DNA that resembles a functional tubulin beta gene but contains mutations or structural features (such as lack of transcription, nonsense mutations, frameshifts, or intron loss) that prevent it from being expressed as a functional protein[1][7]. Pseudogenes like TUBBP2 do not produce a protein product and are not known to have canonical biological or pharmacological roles. As such, TUBBP2 is not considered a therapeutic target and would not be the focus of drug development or diagnostic biomarker efforts[7].

Other names: Tubulin beta pseudogene 2TUBBP2

Beyond the preview

Go deeper on Tubulin beta pseudogene 2 (TUBBP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin beta pseudogene 2 (TUBBP2).

Explore the full profile